Important Safety Information for Helixate^®FS

Helixate^® FS should be administered cautiously in patients with previous hypersensitivity to constituents of FVIII preparations of known sensitivity to mouse or hamster protein.

Adverse events are generally minor. The most common adverse events include injection-site reactions, dizziness, and rash.

For more information about Helixate^® FS, please see full Prescribing Information.